Subversion technology in the medical imaging industry.

Learn that medical equipment companies Shenzhen Frame Guande Technology Co., Ltd. (hereinafter referred to as: Frame View Dexin Xpectvision) completed nearly RMB 100 million B round of financing, led by Shenzhen Times Bole Ventures, and the investors can not disclose.

Starting | R&D area array quantum counting X-ray detector and complete machine system,

Frame view of the core financing history (from whale standard)

Frame Guan Dexin founder Cao Peiyan said that this round of financing is mainly used in two aspects: 1) performance optimization of the face array quantum counting x-ray detection chip, acceleration of breast machine development and product registration certification and The whole machine is trial-produced; 2) New product development such as TOMO version of mammography machine, synchrotron radiation detector, ultra-low dose DSA angiography, XRF detector, etc.

About Frame View, has been introduced in detail, it was founded in 2015 It is mainly engaged in the development of a new generation of surface array X-ray quantum counting (also known as photon counting) detector chip and complete machine production. It has obtained 16 patents in the United States, China, Japan, Singapore, Taiwan and other countries or regions. Covers a large number of underlying core technologies such as semiconductor devices, integrated circuits, and manufacturing processes.

Relying on the above technologies and products, Frame View Decore has officially launched the mammography target DR device last year – belonging to the world’s first “area array quantum counting molybdenum target” Next, it will release the world’s first array-type quantum counting mammography machine, synchrotron radiation detectors and other products.

Starting | R&D area array quantum counting X-rayDetector and machine system,

The Quantum Cleansing Mammography Machine will be launched by Vision (from official website)

According to the current product matrix that has been landed, the frame view of Decore is mainly for breast-related diseases. According to the World Health Organization’s statistics on breast diseases, about 1.2 million women worldwide suffer from breast cancer each year, of which about 500,000 die of breast cancer. One woman is diagnosed with breast cancer every 26 seconds. One person died of breast cancer every minute. Early detection, early diagnosis, and early treatment are currently the best ways to reduce breast cancer mortality.

For early diagnosis of breast cancer, Cao Peiyanin an interview has pointed out that mammography (mammography) photography is the preferred screening method for breast examination, and it is the only statistical data that can effectively reduce breast cancer mortality. Its effectiveness has been global in the past 30 years. The large sample statistics are rigorously proved, while ultrasound and MRI are only used as supplementary inspection measures.

Understanding that the most effective (and only) two techniques for breast cancer X-ray (molybdenum target) photography are amorphous selenium technology (typical) There are Hologic’s new Selenia digital mammography, and Philips’ microdose technology, which uses quantum counting technology to provide static image performance over amorphous selenium mammography.

Relatively, the frame-viewing core detector combines “quantum counting” with “area-array” (relative to the line scan method used by Mulan technology), and the imaging speed is fast. And the product is not sensitive to temperature and humidity, and even adapt to the mobile scene; in addition, has the characteristics of high resolution, high definition, zero dark noise, and has obvious advantages in service life, reliability, cost and productivity. .

Rely on the above techniquesSurgery, Cao Peiyan said that the frame Guande core can independently lay out mammography machine, breast TOMO, intraoral tooth piece machine, dental CT, ultra low dose digital subtraction angiography machine (DSA), energy spectrum dynamic digital X-ray machine (DR), etc. Medical devices, “ These areas together account for almost half of the entire medical imaging industry’s output value.”

He pointed out that , Quantum counting CT and DSA can reduce radiation dose by 70%-90%, which frees the device from dependence on high-power bulbs (Using a low-power ball tube), reducing manufacturing difficulty and localization, the advantages of European and American giants will be weakened. Next, the company will also launch a quantum counter intraoral dental detector, quantum counting dental CT, and will enter the quantum counting energy spectrum whole body CT in the future. It is reported that Siemens’ quantum technology spectrum CT has entered the clinical experiment stage, and all the parameters that have been published exceed its most advanced traditional CT.

In the field of array-array quantum technology detectors, Cao Peiyan told that currently including frame-viewing cores, only 3-4 of the world’s breast and intraoral dental quantum counts have been detected. Industrialization, wheremultiX and Directconversion have been acquired by Siemens and Varian respectively.

Investment logic, Time Bole partner Zhou Bo said that the market share of X-ray-related imaging products currently accounts for more than 70% of the entire medical imaging market, and is a trillion-scale market just as needed; Growth, consumption upgrades, and imaging technology advancement will continue to expand. The technical innovation of the X-ray detection team will fill the gap in the world and have great potential for industrial development.

Team, framed Dexin founder Cao Peiyan graduated from the Department of Electronic Engineering of Tsinghua University with a master’s degree from the University of Texas at Austin, then at the CHESS National High Energy Physics Laboratory and Texas at Cornell University. The University of Austin conducts doctoral research and has participated in the research and development of the latest generation of synchrotron radiation detectors in the United States. It has more than 150 international PCT patents covering inventions ranging from basic semiconductor devices, semiconductor processes, circuit design to complete machines and algorithms.

Extended reading

The world’s first “area array quantum counting molybdenum target” is in mass production, and breast cancer screening may face Reshuffle